share_log

Allmed Medical Products' (SZSE:002950) Shareholders Have More To Worry About Than Only Soft Earnings

Simply Wall St ·  May 7, 2022 10:18

Allmed Medical Products Co., Ltd's (SZSE:002950) stock rose after its recent weak earnings report. Sometimes, shareholders are willing to ignore soft numbers with the hope that they will improve, but our analysis suggests this is unlikely for Allmed Medical Products.

See our latest analysis for Allmed Medical Products

SZSE:002950 Earnings and Revenue History May 7th 2022

How Do Unusual Items Influence Profit?

Importantly, our data indicates that Allmed Medical Products' profit received a boost of CN¥80m in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Allmed Medical Products.

Our Take On Allmed Medical Products' Profit Performance

Arguably, Allmed Medical Products' statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Allmed Medical Products' statutory profits are better than its underlying earnings power. But the good news is that its EPS growth over the last three years has been very impressive. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you want to do dive deeper into Allmed Medical Products, you'd also look into what risks it is currently facing. At Simply Wall St, we found 2 warning signs for Allmed Medical Products and we think they deserve your attention.

This note has only looked at a single factor that sheds light on the nature of Allmed Medical Products' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment